WHO grade I meningiomas: classification-tree for prognostic factors of survival
- PMID: 31183587
- DOI: 10.1007/s10143-019-01117-0
WHO grade I meningiomas: classification-tree for prognostic factors of survival
Abstract
World Health Organization (WHO) grade I meningiomas are intracranial extracerebral tumors, in which microsurgery as a stand-alone therapy provides high rates of disease control and low recurrence rates. Our aim was to identify prognostic factors of overall survival and time-to-retreat (OS; TTR) in a cohort of patients with surgically managed WHO grade I meningioma. Patients with WHO grade I meningiomas from a retrospectively (1990 to 2002) and prospectively managed (2003 to 2010) databank of Oslo University Hospital, Norway, were included. The mean follow-up was 9.2 ± 5.7 years, with a total of 11,414 patient-years. One thousand three hundred fifty-five patients were included. The mean age was 58 ± 13.2, mean Karnofsky Performance Status (KPS) 92.6 ± 26.1 and female-to-male ratio 2.5:1. The 1-year, 5-year, 10-year, 15-year, and 20-year probabilities were 0.98, 0.91, 0.87, 0.84, and 0.8 for TTR. Patient age (OR 0.92 [0.91, 0.94]), male sex (OR 0.59 [0.45, 0.76]), preoperative KPS ≥ 70 (OR 2.22 [1.59, 3.13]), skull base location (OR 0.77 [0.60, 1]), and the occurrence of a postoperative hematoma (OR 0.44 [0.26, 0.76]) were identified as independent prognostic factors of OS. Patient age (OR 1.02 [1.01, 1.03]) and skull base location (OR 0.30 [0.21, 0.45]) were independent predictors of decreased PFS. Using a recursive partitioning analysis, we suggest a classification tree for the prediction of 5-year PFS based on patient and tumor characteristics. The findings from this cohort of meningioma WHO I patients helps to identify patients at risk of recurrence and tailor the therapeutic management.
Keywords: Meningioma; Overall survival; Prognostic factors; Time-to-retreat; WHO grade I.
Similar articles
-
The Simpson grading revisited: aggressive surgery and its place in modern meningioma management.J Neurosurg. 2016 Sep;125(3):551-60. doi: 10.3171/2015.9.JNS15754. Epub 2016 Jan 29. J Neurosurg. 2016. PMID: 26824369
-
Long-term surgical outcome and biological prognostic factors in patients with skull base meningiomas.J Neurosurg. 2011 May;114(5):1278-87. doi: 10.3171/2010.11.JNS10701. Epub 2010 Dec 17. J Neurosurg. 2011. PMID: 21166572
-
Differential Tumor Progression Patterns in Skull Base Versus Non-Skull Base Meningiomas: A Critical Analysis from a Long-Term Follow-Up Study and Review of Literature.World Neurosurg. 2018 Apr;112:e74-e83. doi: 10.1016/j.wneu.2017.12.035. Epub 2017 Dec 16. World Neurosurg. 2018. PMID: 29258946 Review.
-
Prognostic factors for patients with World Health Organization grade III meningiomas treated at a single center.Medicine (Baltimore). 2017 Jun;96(26):e7385. doi: 10.1097/MD.0000000000007385. Medicine (Baltimore). 2017. PMID: 28658170 Free PMC article.
-
Grading of meningiomas.J Clin Neurosci. 2001 May;8 Suppl 1:1-7. doi: 10.1054/jocn.2001.0867. J Clin Neurosci. 2001. PMID: 11386816 Review. No abstract available.
Cited by
-
Why we need new classification models in meningioma management.Acta Neurochir (Wien). 2022 May;164(5):1381-1383. doi: 10.1007/s00701-022-05127-8. Epub 2022 Jan 24. Acta Neurochir (Wien). 2022. PMID: 35067786 No abstract available.
-
Comparative Analysis of the MRI Characteristics of Meningiomas According to the 2016 WHO Pathological Classification.Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820983287. doi: 10.1177/1533033820983287. Technol Cancer Res Treat. 2020. PMID: 33356976 Free PMC article.
-
Neuropsychological Outcomes after Surgery for Olfactory Groove Meningiomas.Cancers (Basel). 2021 May 21;13(11):2520. doi: 10.3390/cancers13112520. Cancers (Basel). 2021. PMID: 34063924 Free PMC article.
-
The efficacy of preoperative MRI features in the diagnosis of meningioma WHO grade and brain invasion.Front Oncol. 2023 Jan 18;12:1100350. doi: 10.3389/fonc.2022.1100350. eCollection 2022. Front Oncol. 2023. PMID: 36741697 Free PMC article.
-
Management of Recurrent Meningiomas: State of the Art and Perspectives.Cancers (Basel). 2022 Aug 18;14(16):3995. doi: 10.3390/cancers14163995. Cancers (Basel). 2022. PMID: 36010988 Free PMC article. Review.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous